Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elders rural services australia limited - alpha-cypermethrin; hydrocarbon liquid - emulsifiable concentrate - alpha-cypermethrin pyrethroid active 100.0 g/l; hydrocarbon liquid solvent other 760.0 g/l - insecticide

United States - English - NLM (National Library of Medicine)

mutual pharmaceutical company - dextroamphetamine saccharate (unii: g83415v073) (dextroamphetamine - unii:tz47u051fi), amphetamine aspartate (unii: h527kap6l5) (amphetamine - unii:ck833kgx7e), dextroamphetamine sulfate (unii: jj768o327n) (dextroamphetamine - unii:tz47u051fi), amphetamine sulfate (unii: 6dpv8nk46s) (amphetamine - unii:ck833kgx7e) - tablet - 1.25 mg - dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate tablets are indicated for the treatment of attention deficit hyperactivity disorder (adhd) and narcolepsy. a diagnosis of attention deficit hyperactivity disorder (adhd; dsm-iv® ) implies the presence of hyperactive-impulsive or inattentive symptoms that caused impairment and were present before age 7 years. the symptoms must cause clinically significant impairment, e.g., in social, academic, or occupational functioning, and be present in two or more settings, e.g., school (or work) and at home. the symptoms must not be better accounted for by another mental disorder. for the inattentive type, at least six of the following symptoms must have persisted for at least 6 months: lack of attention to details/careless mistakes; lack of sustained attention; poor listener; failure to follow through on tasks; poor organization; avoids tasks requiring sustained mental effort; loses things; easily distracted; forgetful

United States - English - NLM (National Library of Medicine)

washington homeopathic products - asparagus - to relieve the symptoms of head cold. indications: asparagus   head cold if symptoms persist/worsen or if pregnant/nursing, stop use and consult your practitioner.

United States - English - NLM (National Library of Medicine)

washington homeopathic products - asparagus - to relieve the symptoms of head cold. indications:  asparagus   head cold if symptoms persist/worsen or if pregnant/nursing, consult your practitioner.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

basf australia ltd. - metiram - dry flowable - metiram carbamate-dithiocarbamate active 700.0 g/kg - fungicide - apple crop = apple orchard | asparagus | banana | bean | broad bean | broccoli | brussels sprouts | cabbage | capsicum or pepper - alternaria leaf blight or spot blight | alternaria leaf spot - alternaria spp. | anthracnose - c. gloeosporides | anthracnose on bean | anthracnose on vines/rubus spp. | apple scab | ascochyta blight | bitter rot | black pit | black spot | black spot/scab in apple/pear | blue mould | blue mould on tobacco | botrytis | brown spot on tobacco | cercospora leaf spot | chocolate spot on bean | cordana leaf spot | downy mildew | downy mildew on cole crop/brassica | downy mildew on cucurbit | downy mildew on grape | downy mildew on lettuce | early blight on celery | early blight or target blackspot | fly speck | frog eye spot on tobacco | fruit speckle - deightoniella torulosa | gummy stem blight or spur blight | late blight or leaf spot | late or irish blight on tomato or potato | leaf spot | pear scab | phomopsis cane | puccinia rust | purple blotch | ring spot on brassica/cole crop | ripe fruit spot | rust | rust - uromyces appendiculatus | septoria spot on lettuce | septoria spot on tomato | shot hole | sooty bl

European Union - English - EMA (European Medicines Agency)

baxalta innovations gmbh - pegaspargase - precursor cell lymphoblastic leukemia-lymphoma - antineoplastic agents, - oncaspar is indicated as a component of antineoplastic combination therapy in acute lymphoblastic leukaemia (all) in paediatric patients from birth to 18 years, and adult patients.,

United States - English - NLM (National Library of Medicine)

baxalta us inc. - pegaspargase (unii: 7d96ir0ppm) (pegaspargase - unii:7d96ir0ppm) - pegaspargase 750 [iu] in 1 ml - oncaspar® is indicated as a component of a multi-agent chemotherapeutic regimen for the first-line treatment of pediatric and adult patients with all. oncaspar is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of pediatric and adult patients with all and hypersensitivity to native forms of l-asparaginase. oncaspar is contraindicated in patients with a: - history of serious hypersensitivity reactions, including anaphylaxis, to oncaspar or to any of the excipients [see warnings and precautions (5.1)] . - history of serious thrombosis with prior l-asparaginase therapy [see warnings and precautions (5.2)] . - history of pancreatitis, including pancreatitis related to prior l-asparaginase therapy [see warnings and precautions (5.3)] . - history of serious hemorrhagic events with prior l-asparaginase therapy [see warnings and precautions (5.5)] . - severe hepatic impairment [see warnings and precautions (5.6)] . risk summary there are no available data on the use of oncaspar i

European Union - English - EMA (European Medicines Agency)

les laboratoires servier - pegaspargase - precursor cell lymphoblastic leukemia-lymphoma - antineoplastic agents, - oncaspar is indicated as a component of antineoplastic combination therapy in acute lymphoblastic leukaemia (all) in paediatric patients from birth to 18 years, and adult patients.,

United States - English - NLM (National Library of Medicine)

servier pharmaceuticals llc - pegaspargase (unii: 7d96ir0ppm) (pegaspargase - unii:7d96ir0ppm) - oncaspar® is indicated as a component of a multi-agent chemotherapeutic regimen for the first-line treatment of pediatric and adult patients with all. oncaspar is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of pediatric and adult patients with all and hypersensitivity to native forms of l-asparaginase. oncaspar is contraindicated in patients with a: - history of serious hypersensitivity reactions, including anaphylaxis, to oncaspar or to any of the excipients [see warnings and precautions (5.1)] . - history of serious thrombosis with prior l-asparaginase therapy [see warnings and precautions (5.2)] . - history of pancreatitis, including pancreatitis related to prior l-asparaginase therapy [see warnings and precautions (5.3)] . - history of serious hemorrhagic events with prior l-asparaginase therapy [see warnings and precautions (5.5)] . - severe hepatic impairment [see warnings and precautions (5.6)] . risk summary based on published literature studies with l-asparaginase in pregnant animals, oncaspar can cause fetal harm when administered to a pregnant woman. there are no available data on oncaspar use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. published literature studies in pregnant animals suggest asparagine depletion may cause harm to the animal offspring (see data) . advise pregnant women of the potential risk to a fetus. in the u.s. general population, the estimated background risks of major birth defects and miscarriage in clinically recognized pregnancies are 2 to 4% and 15 to 20%, respectively. data animal data animal reproduction studies have not been conducted with oncaspar to evaluate its effect on reproduction and fetal development. published literature studies in which pregnant rabbits were administered l-asparaginase or pregnant rats were deprived of dietary asparagine suggested harm to the animal offspring. risk summary there are no data on the presence of pegaspargase in human milk, the effects on the breastfed child, or the effects on milk production. because of the potential for adverse reactions in the breastfed child, advise women not to breastfeed during treatment with oncaspar and for 1 month after the last dose. oncaspar can cause fetal harm when administered to a pregnant woman [see use in specific populations (8.1)] . pregnancy pregnancy testing is recommended in females of reproductive potential prior to initiating oncaspar. contraception advise females of reproductive potential to use effective non-hormonal contraceptive methods during treatment with oncaspar and for 3 months after the last dose. the safety and effectiveness of oncaspar in the treatment of all have been established in pediatric patients. use of oncaspar in these age groups is supported by evidence of efficacy as first-line treatment from one adequate and well-controlled trial, and evidence of efficacy for treatment of patients with hypersensitivity to asparaginase from four adequate and well-controlled trials [see clinical studies (14.1)] , and safety data from 7 total trials. the pediatric patients treated with oncaspar 2,500 international units/m2 on these trials included 26 infants (1 month to <2 years old), 165 children (2 years to <12 years old), and 39 adolescents (12 to 17 years old). clinical studies of oncaspar did not include sufficient numbers of subjects aged 65 years and older to determine whether they respond differently than younger subjects.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nufarm australia limited - clomazone; liquid hydrocarbon - emulsifiable concentrate - clomazone oxazolidinone active 480.0 g/l; liquid hydrocarbon solvent other 450.0 g/l - herbicide - cucurbit | french bean | green bean | navy bean | poppy | potato | rice | tobacco transplant | cantaloupe | choko | combine sown - amaranth - suppression | amaranth or amaranthus | apple-of-peru | barnyard or water grass | blackberry nightshade | fat hen | pigweed spp. | potato or yellow weed | silver top grass - suppression | stagger weed | wild radish - suppression | wireweed, knotweed or hogweed | annual pigweed | barnyard grass | black nightshade | brown beetle grass | fallopia aviculare | field stachys | galinsoga | gooseberry | hedge-nettle | mint weed | munyeroo | portulaca oleracea | prince of wales feather | purslane | stachys orientalis | trianthema decandra | trianthema galericulata | white goosefoot | wild gooseberry | zaleya decandra | zaleya galericulata